People

Aishwarya Sukumar
Aishwarya Sukumar, known publicly as Aishu, described leading Gates Ventures Alzheimer’s efforts and the Diagnostics Accelerator partnership with ADDF in her June 2024 StartUp Health interview. Her background includes research in oncology and neurodegeneration, a translational fellowship at Harvard’s Wyss Institute and healthcare startup/commercialization work. A published 2026 CTAD preliminary program confirms her Gates Ventures affiliation; the planned conference presentation is not represented as completed.
Roles
Gates Ventures
CurrentAlzheimer’s research and Diagnostics Accelerator lead